Cisplatin accord fachinfo
WebCisplatin is only given by injection into a vein (an intravenous infusion). Supportive equipment should be available to control anaphylactic reactions. Cisplatin should not come into contact with any materials that contain aluminium. The recommended dosage of Cisplatin depends on your well-being, the WebFACHINFORMATION Cisplatin Teva®1 mg / ml Konzentrat zur Herstellung einer Infusionslösung. 4 rund 21 Tagen ist ein Abfallen der Throm- bozytenzahl zu …
Cisplatin accord fachinfo
Did you know?
WebBehandlung mit Cisplatin eine aus-reichende Diurese zu gewährleisten. Für diesen Zweck wird die folgende Lösung intravenös infundiert: Natriumchloridlösung 0,9 % Art der … Webexperienced nephrotoxicity as a result of cisplatin therapy. The carcinogenic potential of carboplatin has not been studied but compounds with similar mechanisms of action and …
WebPemetrexed Accord in combination with cisplatin The recommended dose of Pemetrexed Accord is 500 mg/m2 of body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle. The recommended dose of cisplatin is 75 mg/m2 BSA infused over two hours approximately 30 minutes after completion Weboder bei mit Cisplatin vorbehandelten Patienten zu. Der Patient sollte neuro-logisch überwacht und in regelmä-ßigen Abständen neurologisch unter-sucht werden. Bei …
WebCisplatin Solution Accord-UK Products Cisplatin Solution Active Ingredients Cisplatin Report a side effect or a product complaint Cisplatin 1mg/ml Concentrate for solution for … WebCisplatin Accord® 10 mg/10 ml. Dosierung: 10 mg/10 ml. Darreichungsform: Durchstechflasche. Packungsgrösse: 1. Galenische Form: Konzentrat zur Herstellung …
WebNov 30, 2024 · If cisplatin is used in combination chemotherapy, the dose of cisplatin must be reduced. A typical dose is 20 mg/m 2 or more once every 3 to 4 weeks unless in the combination therapy of small-cell and non-small-cell lung carcinoma, in which a typical dose of 80 mg/m 2 is administered.
WebCisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and/or radiotherapy. CONTRAINDICATIONS Cisplatin is contraindicated in patients with preexisting renal impairment. ceska posta blatnaWebCisplatin Accord 1 mg/ml konsentrat til infusjonsvæske UK/H/2862/001 08-6418 ACCORD HEALTHCARE LIMITED NO Cisplatina Accord 1 mg/ml concentrado para solução para … ceska putarinaWebSep 18, 2024 · Cisplatin is a medication used to manage and treat solid tumors and hematologic malignancies. It is in the alkylating agent class of cytotoxic medications. … ceska posta strakoniceWebCisplatin Accord 1 mg/1 mL is available as a 10 mg/10 mL, 25 mg/25 mL, 50 mg/50 mL and 100 mg/100 mL solution for injection. For the full list of excipients, see . Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM . Solution for injection . Cisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg ... ceska posta tracking balikuWebPage 7/10 Safety Data Sheet acc. to OSHA HCS Printing date 09/09/2024 Revision date 09/09/2024 Trade name:Cisplatin (Contd. from page 6) 53.1.21 · Primary irritant effect: · on the skin:No irritant effect. · on the eye:Strong irritant with the danger of severe eye injury. · Sensitization: Sensitization possible through inhalation. ceska posta jeseniceWebCisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung. 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG. 1 ml des Konzentrats zur Herstellung einer Infusionslösung enthält 1 mg Cisplatin. 10 ml des Konzentrats zur Herstellung einer Infusionslösung enthalten 10 mg Cisplatin. ceska posta havirovWebA document describing the properties and the officially approved conditions of use of a medicine. Summaries of product characteristics form the basis of information for healthcare professionals on how to use the medicine safely and effectively. Abbreviated as SmPC. ceska pravnicka komora